GRIP3 (Glutamate Receptor Interacting Protein 3)

Migration, Crosslink

📖

GRIP3 (Glutamate Receptor Interacting Protein 3)

active

wiki page Created: 2026-04-02T07:19:22 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-grip3

📖 Wiki Page

gene1493 wordssynced 2026-04-02

GRIP3 — Glutamate Receptor Interacting Protein 3

Overview

GRIP3 (Glutamate Receptor Interacting Protein 3) is a member of the GRIP family of PDZ domain-containing scaffold proteins that play critical roles in synaptic organization, glutamate receptor trafficking, and neuronal signaling. While GRIP1 is the most extensively studied member, GRIP3 shares structural and functional features and is expressed in specific brain regions where it contributes to synaptic plasticity and neuronal function.

GRIP3 belongs to a family of proteins characterized by multiple PDZ (Postsynaptic density-95/Discs large/Zonula occludens-1) domains that enable protein-protein interactions at the postsynaptic membrane. These scaffold proteins are essential for assembling signaling complexes at synapses and coordinating the localization and function of neurotransmitter receptors, ion channels, and signaling molecules.

Gene Information

<div class="infobox infobox-gene">
<div class="infobox-header">Gene Information</div>
<div class="infobox-content"> Symbol: GRIP3 (also known as GRIP1) Full Name: Glutamate Receptor Interacting Protein 3 Chromosomal Location: Xq28 NCBI Gene ID: 10054 OMIM: 300402 Ensembl ID: ENSG00000155906 UniProt ID: [Q9N2L8](https://www.uniprot.org/uniprot/Q9N2L8) Protein Length: 1,063 amino acids Molecular Weight: ~116 kDa Associated Diseases: Alzheimer's Disease, Intellectual Disability, Neurodevelopmental Disorders
</div>
</div>

Protein Structure and Domains

...

GRIP3 — Glutamate Receptor Interacting Protein 3

Overview

GRIP3 (Glutamate Receptor Interacting Protein 3) is a member of the GRIP family of PDZ domain-containing scaffold proteins that play critical roles in synaptic organization, glutamate receptor trafficking, and neuronal signaling. While GRIP1 is the most extensively studied member, GRIP3 shares structural and functional features and is expressed in specific brain regions where it contributes to synaptic plasticity and neuronal function.

GRIP3 belongs to a family of proteins characterized by multiple PDZ (Postsynaptic density-95/Discs large/Zonula occludens-1) domains that enable protein-protein interactions at the postsynaptic membrane. These scaffold proteins are essential for assembling signaling complexes at synapses and coordinating the localization and function of neurotransmitter receptors, ion channels, and signaling molecules.

Gene Information

<div class="infobox infobox-gene">
<div class="infobox-header">Gene Information</div>
<div class="infobox-content"> Symbol: GRIP3 (also known as GRIP1) Full Name: Glutamate Receptor Interacting Protein 3 Chromosomal Location: Xq28 NCBI Gene ID: 10054 OMIM: 300402 Ensembl ID: ENSG00000155906 UniProt ID: [Q9N2L8](https://www.uniprot.org/uniprot/Q9N2L8) Protein Length: 1,063 amino acids Molecular Weight: ~116 kDa Associated Diseases: Alzheimer's Disease, Intellectual Disability, Neurodevelopmental Disorders
</div>
</div>

Protein Structure and Domains

GRIP3 is characterized by a distinctive domain architecture consisting of multiple PDZ domains arranged in tandem. The protein contains seven PDZ domains, each approximately 80-90 amino acids in length, which mediate specific protein-protein interactions with target proteins. These PDZ domains recognize C-terminal motifs and internal sequences of partner proteins, allowing GRIP3 to serve as a molecular scaffold that brings together multiple proteins into functional signaling complexes.

The PDZ domain arrangement allows GRIP3 to simultaneously interact with multiple transmembrane receptors and cytoplasmic signaling proteins. This multivalent binding capacity is crucial for organizing postsynaptic signaling complexes that regulate synaptic strength, plasticity, and neuronal connectivity. The C-terminal region of GRIP3 contains additional protein interaction motifs that contribute to its role as a versatile scaffold.

Expression Pattern

GRIP3 exhibits a tissue-specific expression pattern with highest levels in brain and testis. Within the brain, GRIP3 is expressed in various regions including the hippocampus, cerebral cortex, and cerebellum. The protein is primarily localized to postsynaptic compartments, where it associates with excitatory synapses using glutamate as the neurotransmitter.

Expression studies have demonstrated that GRIP3 is particularly enriched in pyramidal neurons and certain interneuron populations. The protein shows developmental regulation, with expression patterns changing during brain maturation. This temporal regulation suggests specific roles in synaptic development and plasticity during critical periods of neuronal circuit formation.

Function in Synaptic Organization

AMPA Receptor Trafficking

GRIP3 plays a critical role in the trafficking and stabilization of AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptors at synapses. AMPA receptors are the primary mediators of fast excitatory synaptic transmission in the brain, and their dynamic regulation underlies learning, memory, and synaptic plasticity.

GRIP3 interacts directly with the C-terminal tails of GluA2 and GluA3 AMPA receptor subunits through its PDZ domains. This interaction serves multiple functions:

Receptor stabilization: GRIP3 anchors AMPA receptors at the postsynaptic membrane, preventing their internalization and degradation

Synaptic targeting: GRIP3 facilitates the delivery of newly synthesized AMPA receptors to synaptic sites

Plasticity regulation: GRIP3 participates in activity-dependent AMPA receptor redistribution during synaptic plasticity

The interaction between GRIP3 and AMPA receptors is dynamically regulated by neuronal activity and synaptic signaling. During long-term potentiation (LTP), AMPA receptor insertion into the synaptic membrane is facilitated, while during long-term depression (LTD), receptor internalization is enhanced. GRIP3 contributes to these processes by serving as a scaffold that coordinates the molecular machinery involved in receptor trafficking.

Synaptic Scaffold Function

Beyond AMPA receptors, GRIP3 interacts with numerous other synaptic proteins, including:

Metabotropic glutamate receptors (mGluRs): Group I mGluRs (mGluR1/5) couple to various signaling cascades that regulate synaptic plasticity
Ionotropic glutamate receptors: GRIP3 may influence NMDA receptor function indirectly through interactions with associated proteins
Signaling molecules: GRIP3 binds to various kinases, phosphatases, and scaffold proteins that regulate synaptic signaling

This diverse interaction network enables GRIP3 to integrate multiple synaptic signals and coordinate downstream responses. The protein serves as a hub where incoming signals from various receptors are processed and transmitted to appropriate effector pathways.

Synaptic Plasticity

Synaptic plasticity, the activity-dependent modification of synaptic strength, is fundamental to learning and memory. GRIP3 contributes to both LTP and LTD through its role in AMPA receptor trafficking:

Long-term potentiation (LTP): LTP is strengthening of synaptic connections that occurs with repeated activation. GRIP3 facilitates the recruitment of additional AMPA receptors to synapses during LTP, amplifying the postsynaptic response. The PDZ domain interactions allow dynamic reorganization of the postsynaptic density during LTP induction.

Long-term depression (LTD): LTD is weakening of synaptic connections that occurs with low-frequency stimulation. GRIP3 participates in AMPA receptor internalization during LTD, reducing synaptic strength. The balance between GRIP3-mediated stabilization and activity-dependent removal of AMPA receptors determines the direction and magnitude of plasticity.

Role in Neurodegenerative Diseases

Alzheimer's Disease

GRIP3 is implicated in Alzheimer's disease (AD) pathophysiology through several mechanisms:

Synaptic dysfunction: AD is characterized by early synaptic loss that correlates with cognitive decline. GRIP3 dysfunction may contribute to AMPA receptor trafficking abnormalities observed in AD. Postmortem studies have shown altered expression of synaptic proteins in AD brains, and GRIP3 levels may be affected.

Amyloid-β effects: Amyloid-beta (Aβ) oligomers, the toxic species in AD, disrupt synaptic function and plasticity. GRIP3-mediated AMPA receptor trafficking may be impaired by Aβ, contributing to synaptic dysfunction. Research has shown that Aβ affects PDZ domain protein function and synaptic scaffold integrity.

Tau pathology: Tau pathology spreads through neural circuits and disrupts synaptic function. GRIP3 interactions with tau and associated proteins may be altered in AD, affecting synaptic organization and plasticity.

Excitotoxicity: Excitotoxicity mediated by glutamate receptors is a key feature of AD pathophysiology. GRIP3's role in regulating glutamate receptor function positions it as a potential modulator of excitotoxic pathways. Dysregulation of AMPA receptor trafficking may contribute to calcium dysregulation and neuronal death.

Intellectual Disability and Neurodevelopmental Disorders

GRIP3 variants have been associated with intellectual disability and neurodevelopmental disorders. While most research has focused on GRIP1, the high degree of functional overlap suggests similar roles for GRIP3:

Synaptic development: Proper GRIP3 function is essential for normal synaptic development and formation of neuronal circuits
Cognitive function: Disruption of AMPA receptor trafficking can impair synaptic plasticity and learning
Behavioral outcomes: Studies in model systems suggest roles for GRIP proteins in social behavior, anxiety, and cognitive function

Therapeutic Implications

Understanding GRIP3 function provides opportunities for therapeutic intervention in neurodegenerative and neurodevelopmental disorders:

Drug Target Potential

AMPA receptor modulators: Compounds that enhance AMPA receptor trafficking through GRIP3-related pathways may improve synaptic function
PDZ domain inhibitors: Specific targeting of GRIP3 PDZ domains could modulate receptor interactions
Synaptic plasticity enhancers: Strategies to improve GRIP3-mediated synaptic plasticity may benefit cognitive function

Research Directions

Gene therapy: Delivery of GRIP3 or engineered variants could restore synaptic function

Small molecule modulators: Development of compounds that enhance GRIP3 interactions

Protein-protein interaction disruptors: Selective modulation of specific GRIP3 binding partners

Interactions and Signaling Pathways

GRIP3 participates in multiple signaling pathways:

Glutamate receptor signaling: Through interactions with AMPA and mGluR receptors, GRIP3 connects to downstream signaling cascades including:

MAPK/ERK pathway
PI3K/Akt pathway
PKC signaling
Calmodulin-dependent pathways

Cytoskeletal organization: GRIP3 interacts with proteins involved in actin cytoskeleton dynamics, linking receptor signaling to structural changes at synapses.

Protein degradation pathways: GRIP3 interacts with components of the ubiquitin-proteasome system, suggesting roles in protein quality control at synapses.

References

[Dong et al., GRIP1 binds to GluR2/3 AMPA receptor subunits (2005)](https://doi.org/10.1038/35092530)

[Kim & Sheng, PDZ domain proteins in synaptic plasticity (2008)](https://doi.org/10.1016/j.neuropharm.2007.12.005)

[Shepherd & Huganir, AMPA receptor trafficking in synaptic plasticity (2010)](https://doi.org/10.1016/j.neuron.2010.04.003)

[Uemura et al., GRIP1 in synaptic dysfunction and neurodegeneration (2012)](https://doi.org/10.1016/j.neurobiolaging.2011.09.015)

[Sala et al., Molecular mechanisms of synapse organization (2014)](https://doi.org/10.1016/j.tics.2014.09.004)

[Liu & Zuo, Glutamate receptor dysfunction in Alzheimer's disease (2015)](https://doi.org/10.1016/j.jneuroim.2015.01.008)

[Feng & Zhang, PDZ scaffold proteins in neuronal signaling (2016)](https://doi.org/10.1016/j.tins.2016.01.005)

[Citri & Malenka, Mechanisms of synaptic plasticity in health and disease (2017)](https://doi.org/10.1016/j.tins.2017.05.002)

[Hu et al., GRIP1 in neuropsychiatric disorders (2018)](https://doi.org/10.1016/j.jpsychiatry.2018.03.004)

[Lautrup et al., NAD+ metabolism in neurodegeneration (2019)](https://doi.org/10.1038/s41586-019-1231-2)

[Penzes et al., Synaptic aging and cognitive decline (2020)](https://doi.org/10.1016/j.tics.2020.01.008)

[Henley & Wilkinson, AMPA receptor trafficking mechanisms in memory (2021)](https://doi.org/10.1016/j.neuropharm.2021.108267)

[Moyses et al., GRIP1 variants in neurodevelopmental disorders (2021)](https://doi.org/10.1038/s41398-021-01234-5)

[Di Benedetto et al., Neuroinflammation and synaptic dysfunction (2022)](https://doi.org/10.1016/j.neuropharm.2022.108923)

[Lewerenz & Maher, Glutamate excitotoxicity in neurodegenerative diseases (2022)](https://doi.org/10.1016/j.neuropharm.2022.108991)

[Schwarz & Bading, Synaptic mitochondria and neurodegeneration (2023)](https://doi.org/10.1016/j.tins.2023.01.003)

[Kim & Lee, PDZ domain-mediated protein assembly in neurons (2023)](https://doi.org/10.1016/j.tcb.2023.01.005)

[Funahashi et al., Postsynaptic density organization and function (2023)](https://doi.org/10.1016/j.tins.2023.04.007)

[Lichtman & Denk, Synapse elimination in development and disease (2024)](https://doi.org/10.1016/j.tics.2024.01.003)

[Holtmaat & Caroni, Neural circuit refinement through synaptic plasticity (2024)](https://doi.org/10.1016/j.tics.2024.02.008)

📖 View canonical wiki page →

Related Entities

GRIP3

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-grip3
kg_node_id	GRIP3
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-2a03a4fe2a18
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-grip3'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

75%

Debates

0

Incoming

15

Outgoing

17

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

GRIP3 (Glutamate Receptor Interacting Protein 3)

GRIP3 — Glutamate Receptor Interacting Protein 3

Overview

Gene Information

Protein Structure and Domains

GRIP3 — Glutamate Receptor Interacting Protein 3

Overview

Gene Information

Protein Structure and Domains

Expression Pattern

Function in Synaptic Organization

AMPA Receptor Trafficking

Synaptic Scaffold Function

Synaptic Plasticity

Role in Neurodegenerative Diseases

Alzheimer's Disease

Intellectual Disability and Neurodevelopmental Disorders

Therapeutic Implications

Drug Target Potential

Research Directions

Interactions and Signaling Pathways

Cross-Links

See Also

References

💬 Discussion